Pharmaceuticals company Merck & Co., Inc. (NYSE: MRK) has reported stronger-than expected earnings and revenues for the fourth quarter. The positive outcome
Infographic: A snapshot of Merck’s Q4 2021 earnings
Categories
Health Care
BIIB Earnings: Key quarterly highlights from Biogen’s Q4 2021 financial results
Biogen Inc. (NASDAQ: BIIB) reported fourth quarter 2021 earnings results today. Total revenue decreased 4% year-over-year to $2.73 billion. GAAP net income
Eli Lilly and Company (LLY) Earnings: 4Q21 Key Numbers
Eli Lilly and Company (NYSE: LLY) reported revenue of $7.9 billion for the fourth quarter of 2021, up 8% year-over-year. Reported net
Humana Inc (HUM) Q4 2021 Earnings Call Transcript
Humana Inc (NYSE: HUM) Q4 2021 earnings call dated Feb. 02, 2022 Corporate Participants: Lisa Stoner -- Vice President of Investor Relations Bruce D.
AbbVie (ABBV) Q4 2021 Earnings Call Transcript
AbbVie (NYSE: ABBV) Q4 2021 earnings call dated Feb. 02, 2022 Corporate Participants: Elizabeth Shea -- Vice President, Investor Relations Richard A. Gonzalez -- Chairman of
Boston Scientific Corp (BSX) Q4 2021 Earnings Call Transcript
Boston Scientific Corp (NYSE: BSX) Q4 2021 earnings call dated Feb. 02, 2022 Corporate Participants: Lauren Tengler -- Vice President, Investor Relations Michael F.
AbbVie (ABBV) Earnings: Key financials and quarterly highlights
AbbVie (NYSE: ABBV) today reported its fourth-quarter financial results for the period ended December 31, 2021. Net revenues increased 7.4% to $14.8
Arcellx readies for $140-mln IPO. Here’s all you need to know
The IPO market is recovering from the slowdown experienced towards the end of 2021, with pharma companies dominating the scene in the
Dr. Reddy’s Laboratories (DRREDDY) Q3 2022 Earnings Call Transcript
Dr. Reddy's Laboratories (NSE: DRREDDY) Q3 2022 earnings call dated Jan. 28, 2022 Corporate Participants: Amit Agarwal -- Head of Investor Relations Parag Agarwal -- Chief
Vertex Pharmaceuticals Incorporated (VRTX) Q4 2021 Earnings Call Transcript
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) Q4 2021 earnings call dated Jan. 26, 2022 Corporate Participants: Michael Partridge -- Senior Vice President of Investor Relations
INTERVIEW: Evelo’s SINTAX medicines could address a broad range of inflammatory disorders
Credit:DavidBGray on iStock Evelo Biosciences (Nasdaq:EVLO) is a clinical-stage biotechnology company that is focused on a newly uncovered area of central human
Abbott Laboratories (ABT) Q4 2021 Earnings Call Transcript
Abbott Laboratories (NYSE: ABT) Q4 2021 earnings call dated Jan. 26, 2022 Corporate Participants: Scott Leinenweber -- Vice President, Investor Relations, Licensing & Acquisitions
Anthem, Inc. (ANTM) Q4 2021 Earnings Call Transcript
Anthem, Inc. (NYSE: ANTM) Q4 2021 earnings call dated Jan. 26, 2022 Corporate Participants: Stephen Tanal -- Vice President, Investor Relations Gail K. Boudreaux -- President
Johnson & Johnson (JNJ) Q4 2021 Earnings Call Transcript
Johnson & Johnson (NYSE: JNJ) Q4 2021 earnings call dated Jan. 25, 2022 Corporate Participants: Jessica Moore -- Vice President, Investor Relations Joseph J. Wolk -- Executive
Johnson & Johnson (JNJ) reports Q4 2021 earnings
Johnson & Johnson (NYSE: JNJ) reported fourth-quarter 2021 financial results before the regular market hours on Tuesday. The pharmaceutical giant reported revenue
Royal Philips NV (PHG) Q4 2021 Earnings Call Transcript
Royal Philips NV (AMS: PHG) Q4 2021 earnings call dated Jan. 24, 2022 Corporate Participants: Leandro Mazzoni -- Head of Investor Relations Frans van
Intuitive Surgical Inc. (ISRG) Q4 2021 Earnings Call Transcript
Intuitive Surgical Inc. (NASDAQ: ISRG) Q4 2021 earnings call dated Jan. 20, 2022 Corporate Participants: Brian King -- Head, Investor Relations Gary S. Guthart -- Chief
UnitedHealth Group Incorporated (UNH) Q4 2021 Earnings Call Transcript
UnitedHealth Group Incorporated (NYSE: UNH) Q4 2021 earnings call dated Jan. 19, 2022 Corporate Participants: Sir Andrew Witty — Chief Executive Officer Dirk McMahon — President
Key highlights from UnitedHealth Group’s (UNH) Q4 2021 earnings results
UnitedHealth Group (NYSE: UNH) reported fourth quarter 2021 earnings results today. Total revenues were $73.7 billion compared to $65.4 billion in the same
Organigram Holdings, Inc. (OGI) Q1 2022 Earnings Call Transcript
Organigram Holdings, Inc. (NASDAQ: OGI) Q1 2022 earnings call dated Jan. 11, 2022 Corporate Participants: Beena Goldenberg -- Chief Executive Officer Derrick West -- Chief Financial
Tilray, inc (TLRY) Q2 2022 Earnings Call Transcript
Tilray, inc (NASDAQ: TLRY) Q2 2022 earnings call dated Jan. 10, 2022 Corporate Participants: Berrin Noorata -- Chief Corporate Affairs Officer Irwin D. Simon -- Chairman